Multi Spunindo Jaya Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Multi Spunindo Jaya Tbk. trades at Rp825 (market cap 5.24T, 16.9M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Multi Spunindo Jaya Tbk. is far larger — about 12.2× Prodia Diagnostic Line Tbk's market cap, and Multi Spunindo Jaya Tbk. is more actively traded (16.9M versus 13.83M). Which is the better fit depends on your goals.
| MSJA | PRDL | |
|---|---|---|
Market Cap | 5.24T | 428.75B |
Volume | 16.9M | 13.83M |
Lot | 169.01K | 138.27K |
Turnover | 13.99B | 3.27B |
Average Price | 827.58 | 236.62 |
Value | 13.99B | 3.27B |
Indicative Equilibrium Price | 825 | 236 |
Indicative Equilibrium Volume | 1.8K | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Spunindo Jaya Tbk (the Company), was established based on Notarial Deed of WahyudiSuyanto, S.H., No. 102 dated March 7, 1997. The Company started its commercial operation in 1999. The Company’s immediate parent company is PT Maju Selaras Jayamerta and the ultimate controlling shareholder of the Company is Sasongko Basuki.
Read more on MSJA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →